Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NUCLEAR ANTIGEN-2' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 113 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Takacs, M; Salamon, D; Myohanen, S; Li, H; Segesdi, J; Ujvari, D; Uhlig, J; Niller, HH; Wolf, H; Berencsi, G; Minarovits, J
      Epigenetics of latent Epstein-Barr virus genomes: High resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes

      BIOLOGICAL CHEMISTRY
    2. Niller, HH; Salamon, D; Takacs, M; Uhlig, J; Wolf, H; Minarovits, J
      Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines

      BIOLOGICAL CHEMISTRY
    3. Zimber-Strobl, U; Strobl, LJ
      EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes

      SEMINARS IN CANCER BIOLOGY
    4. Makar, KW; Ulgiati, D; Hagman, J; Holers, VM
      A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation

      INTERNATIONAL IMMUNOLOGY
    5. Zur Hausen, H
      Oncogenic DNA viruses

      ONCOGENE
    6. Tani, S; Kurooka, H; Aoki, T; Hashimoto, N; Honjo, T
      The N- and C-terminal regions of RBP-J interact with the ankyrin repeats of Notch1 RAMIC to activate transcription

      NUCLEIC ACIDS RESEARCH
    7. Shimakage, M; Sasagawa, T
      Detection of Epstein-Barr virus-determined nuclear antigen-2 mRNA by in situ hybridization

      JOURNAL OF VIROLOGICAL METHODS
    8. Moore, SM; Cannon, JS; Tanhehco, YC; Hamzeh, FM; Ambinder, RF
      Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    9. Rodriguez, A; Jung, EJ; Yin, QY; Cayrol, C; Flemington, EK
      Role of c-myc regulation in Zta-mediated induction of the cyclin-dependentkinase inhibitors p21 and p27 and cell growth arrest

      VIROLOGY
    10. Spender, LC; Cornish, GH; Rowland, B; Kempkes, B; Farrell, PJ
      Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection

      JOURNAL OF VIROLOGY
    11. Salamon, D; Takacs, M; Ujvari, D; Uhlig, J; Wolf, H; Minarovits, J; Niller, HH
      Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus

      JOURNAL OF VIROLOGY
    12. Hofelmayr, H; Strobl, LJ; Marschall, G; Bornkamm, GW; Zimber-Strobl, U
      Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells

      JOURNAL OF VIROLOGY
    13. Gordadze, AV; Peng, RS; Tan, J; Liu, GZ; Sutton, R; Kempkes, B; Bornkamm, GW; Ling, PD
      Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus

      JOURNAL OF VIROLOGY
    14. D'Addario, M; Libermann, TA; Xu, JW; Ahmad, A; Menezes, J
      Epstein-Barr virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappa B and different signaling pathways

      JOURNAL OF MOLECULAR BIOLOGY
    15. McCann, EM; Kelly, GL; Rickinson, AB; Bell, AI
      Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP asa co-activator of EBNA2 function

      JOURNAL OF GENERAL VIROLOGY
    16. Pajic, A; Staege, MS; Dudziak, D; Schuhmacher, M; Spitkovsky, D; Eissner, G; Brielmeier, M; Polack, A; Bornkamm, GW
      Antagonistic effects of C-MYC and Epstein-Barr virus latent genes on the phenotype of human B cells

      INTERNATIONAL JOURNAL OF CANCER
    17. zur Hausen, H
      Viruses in human cancers

      CURRENT SCIENCE
    18. Salamon, D; Takacs, M; Myohanen, S; Marcsek, Z; Berencsi, G; Minarovits, J
      De novo DNA methylation at nonrandom founder sites 5 ' from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes

      BIOLOGICAL CHEMISTRY
    19. Callahan, J; Aster, J; Sklar, J; Kieff, E; Robertson, ES
      Intracellular forms of human NOTCH1 interact at distinctly different levels with RBP-Jkappa in human B and T cells

      LEUKEMIA
    20. Robertson, KD
      The role of DNA methylation in modulating Epstein-Barr virus gene expression

      DNA METHYLATION AND CANCER
    21. Zhou, SF; Fujimuro, M; Hsieh, JJD; Chen, L; Hayward, SD
      A role for SKIP in EBNA2 activation of CBF1-repressed promoters

      JOURNAL OF VIROLOGY
    22. Cotter, M; Callahan, J; Aster, J; Robertson, E
      Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells

      JOURNAL OF VIROLOGY
    23. Yoo, L; Speck, SH
      Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancerduring the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines

      JOURNAL OF VIROLOGY
    24. Tierney, RJ; Kirby, HE; Nagra, JK; Desmond, J; Bell, AI; Rickinson, AB
      Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation

      JOURNAL OF VIROLOGY
    25. Joseph, AM; Babcock, GJ; Thorley-Lawson, DA
      Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils

      JOURNAL OF VIROLOGY
    26. Hanookai, D; Nowzari, H; Contreras, A; Morrison, JL; Slots, J
      Herpesviruses and periodontopathic bacteria in trisomy 21 periodontitis

      JOURNAL OF PERIODONTOLOGY
    27. Lin, CS; Kuo, HH; Chen, JY; Yang, CS; Wang, WB
      Epstein-Barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally

      JOURNAL OF MOLECULAR BIOLOGY
    28. Kirby, H; Rickinson, A; Bell, A
      The activity of the Epstein-Barr virus BamHI W promoter in B cells is dependent on the binding of CREB/ATF factors

      JOURNAL OF GENERAL VIROLOGY
    29. Fais, F; Fronza, G; Roncella, S; Inga, A; Campomenosi, P; Cutrona, G; Pezzolo, A; Fedeli, F; Abbondandolo, A; Chiorazzi, N; Pistoia, V; Ferrarini, M
      Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma

      INTERNATIONAL JOURNAL OF CANCER
    30. Pajic, A; Spitkovsky, D; Christoph, B; Kempkes, B; Schuhmacher, M; Staege, MS; Brielmeier, M; Ellwart, J; Kohlhuber, F; Bornkamm, GW; Polack, A; Eick, D
      Cell cycle activation by c-myc in a Burkitt lymphoma model cell line

      INTERNATIONAL JOURNAL OF CANCER
    31. To, KF; Lai, FMM; Wang, AYM; Leung, CB; Choi, PCL; Szeto, CC; Lui, SF; Yu, AWY; Li, PKT
      Posttransplant Epstein-Barr virus-associated myogenic tumors involving bone - A case report

      CANCER
    32. Falk, KI; Ernberg, I
      Demethylation of the Epstein-Barr virus origin of lytic replication and ofthe immediate early gene BZLF1 is DNA replication independent - Brief Report

      ARCHIVES OF VIROLOGY
    33. Bash, J; Zong, WX; Banga, S; Rivera, A; Ballard, DW; Ron, Y; Gelinas, C
      Rel/NF-kappa B can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors

      EMBO JOURNAL
    34. Fremeaux-Bacchi, V; Kolb, JP; Rakotobe, S; Kazatchkine, MD; Fischer, EM
      Functional properties of soluble CD21

      IMMUNOPHARMACOLOGY
    35. Zimber-Strobl, U; Strobl, L; Hofelmayr, H; Kempkes, B; Staege, MS; Laux, G; Christoph, B; Polack, A; Bornkamm, GW
      EBNA2 and c-myc in B cell immortalization by Epstein-Barr virus and in thepathogenesis of Burkitt's Lymphoma

      MECHANISMS OF B CELL NEOPLASIA 1998
    36. Aguirre, AJ; Robertson, ES
      Characterization of intertypic recombinants of the Epstein-Barr virus fromthe body-cavity-based lymphomas cell lines BC-1 and BC-2

      VIROLOGY
    37. Thorley-Lawson, DA; Babcock, GJ
      A model for persistent infection with Epstein-Barr virus: The stealth virus of human B cells

      LIFE SCIENCES
    38. Sjoblom-Hallen, A; Yang, WW; Jansson, A; Rymo, L
      Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure

      JOURNAL OF VIROLOGY
    39. Fuentes-Panana, EM; Swaminathan, S; Ling, PD
      Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15)

      JOURNAL OF VIROLOGY
    40. Becker, JL; Miller, F; Nuovo, GJ; Josepovitz, C; Schubach, WH; Nord, EP
      Epstein-Barr virus infection of renal proximal tubule cells: possible rolein chronic interstitial nephritis

      JOURNAL OF CLINICAL INVESTIGATION
    41. Holmgren, L; Szeles, A; Rajnavolgyi, E; Folkman, J; Klein, G; Ernberg, I; Falk, KI
      Horizontal transfer of DNA by the uptake of apoptotic bodies

      BLOOD
    42. Tao, Q; Swinnen, LJ; Yang, J; Srivastava, G; Robertson, KD; Ambinder, RF
      Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease - Application of PCR-based analysis

      AMERICAN JOURNAL OF PATHOLOGY
    43. ALHOMSI AS; BERGER C; VANBAARLE D; KERSTEN MJ; KLEIN MR; MCQUAIN C; VANOERS R; KNECHT H
      MOLECULAR ANALYSIS OF CRITICAL SEQUENCES WITHIN THE EBNA-2 TYPE-1 GENE FROM EPSTEIN-BARR-VIRUS ISOLATES FROM PATIENTS WITH INFECTIOUS-MONONUCLEOSIS, TONSILLAR HYPERPLASIA, AND HIV-INFECTION

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    44. KERSTEN MJ; VANGORP J; PALS ST; BOON F; VANOERS MHJ
      EXPRESSION OF EPSTEIN-BARR-VIRUS LATENT GENES AND ADHESION MOLECULES IN AIDS-RELATED NON-HODGKINS-LYMPHOMAS - CORRELATION WITH HISTOLOGY AND CD4-CELL NUMBER

      Leukemia & lymphoma
    45. MANET E; BOURILLOT PY; WALTZER L; SERGEANT A
      EBV GENES AND B-CELL PROLIFERATION

      Critical reviews in oncology/hematology
    46. SHIM YS; KIM CW; LEE WK
      SEQUENCE VARIATION OF EBNA2 OF EPSTEIN-BARR-VIRUS ISOLATES FROM KOREA

      Molecules and cells
    47. TANIERE P; THIVOLETBEJUI F; VITREY D; ISAAC S; LOIRE R; CORDIER JF; BERGER F
      LYMPHOMATOID GRANULOMATOSIS - A REPORT ON 4 CASES - EVIDENCE FOR B-PHENOTYPE OF THE TUMORAL CELLS

      The European respiratory journal
    48. TANIERE P; MANAI A; CHARPENTIER R; TERDJMAN P; BOUCHERON S; CORDIER JF; BERGER F
      PYOTHORAX-ASSOCIATED LYMPHOMA - RELATIONSHIP WITH EPSTEIN-BARR-VIRUS,HUMAN HERPES VIRUS-8 AND BODY CAVITY-BASED HIGH-GRADE LYMPHOMAS

      The European respiratory journal
    49. Rowe, M; Niedobitek, G; Young, LS
      Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders

      SPRINGER SEMINARS IN IMMUNOPATHOLOGY
    50. BRIELMEIER M; BECHET JM; FALK MH; PAWLITA M; POLACK A; BORNKAMM GW
      IMPROVING STABLE TRANSFECTION EFFICIENCY - ANTIOXIDANTS DRAMATICALLY IMPROVE THE OUTGROWTH OF CLONES UNDER DOMINANT MARKER SELECTION

      Nucleic acids research
    51. MASSARI ME; RIVERA RR; VOLAND JR; QUONG MW; BREIT TM; VANDONGEN JJM; DESMIT O; MURRE C
      CHARACTERIZATION OF ABF-1, A NOVEL BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR EXPRESSED IN ACTIVATED B-LYMPHOCYTES

      Molecular and cellular biology
    52. CHEN WP; HUANG S; COOPER NR
      LEVELS OF P53 IN EPSTEIN-BARR VIRUS-INFECTED CELLS DETERMINE CELL FATE - APOPTOSIS, CELL-CYCLE ARREST AT THE G1 S BOUNDARY WITHOUT APOPTOSIS, CELL-CYCLE ARREST AT THE G2/M BOUNDARY WITHOUT APOPTOSIS, OR UNRESTRICTED PROLIFERATION/

      Virology (New York, N.Y. Print)
    53. WEBSTERCYRIAQUE J; RAABTRAUB R
      TRANSCRIPTION OF EPSTEIN-BARR-VIRUS LATENT CYCLE GENES IN ORAL HAIRY LEUKOPLAKIA

      Virology (New York, N.Y. Print)
    54. Bell, A; Skinner, J; Kirby, H; Rickinson, A
      Characterisation of regulatory sequences at the Epstein-Barr virus BamHI Wpromoter

      VIROLOGY
    55. YOSHIZAKI T; SATO H; FURUKAWA M; PAGANO JS
      THE EXPRESSION OF MATRIX METALLOPROTEINASE-9 IS ENHANCED BY EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN-1

      Proceedings of the National Academy of Sciences of the United Statesof America
    56. KULWICHIT W; EDWARDS RH; DAVENPORT EM; BASKAR JF; GODFREY V; RAABTRAUB N
      EXPRESSION OF THE EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN-1 INDUCES B-CELL LYMPHOMA IN TRANSGENIC MICE

      Proceedings of the National Academy of Sciences of the United Statesof America
    57. Afanas'eva, TA; Gurtsevich, VE
      Molecular biological aspects of Epstein-Barr virus-associated carcinogenesis

      MOLECULAR BIOLOGY
    58. YAO QY; CROOMCARTER DSG; TIERNEY RJ; HABESHAW G; WILDE JT; HILL FGH; CONLON C; RICKINSON AB
      EPIDEMIOLOGY OF INFECTION WITH EPSTEIN-BARR-VIRUS TYPE-1 AND TYPE-2 -LESSONS FROM THE STUDY OF A T-CELL-IMMUNOCOMPROMISED HEMOPHILIC COHORT

      Journal of virology
    59. SJOBLOM A; YANG WW; PALMQVIST L; JANSSON A; RYMO L
      AN ATF CRE ELEMENT MEDIATES BOTH EBNA2-DEPENDENT AND EBNA2-INDEPENDENT ACTIVATION OF THE EPSTEIN-BARR-VIRUS LMP1 GENE PROMOTER/

      Journal of virology
    60. FUENTESPANANA EM; LING PD
      CHARACTERIZATION OF THE CBF2 BINDING-SITE WITHIN THE EPSTEIN-BARR-VIRUS LATENCY-C PROMOTER AND ITS ROLE IN MODULATING EBNA2-MEDIATED TRANSACTIVATION

      Journal of virology
    61. MAJOLINI MB; DELIOS MM; GALIENI P; BONCRISTIANO M; LAURIA F; DELPRETE G; TELFORD JL; BALDARI CT
      EXPRESSION OF THE T-CELL-SPECIFIC TYROSINE KINASE LCK IN NORMAL B-1 CELLS AND IN CHRONIC LYMPHOCYTIC-LEUKEMIA-B

      Blood
    62. ALTMEYER A; SIMMONS RC; KRAJEWSKI S; REED JC; BORNKAMM GW; CHENKIANG S
      REVERSAL OF EBV IMMORTALIZATION PRECEDES APOPTOSIS IN IL-6-INDUCED HUMAN B-CELL TERMINAL DIFFERENTIATION

      Immunity
    63. MCCLAIN KM; ESTROV Z; RAJU U; KELLEY PK; AGGARWAL BB
      EPSTEIN-BARR-VIRUS EBNA-2 GENE-EXPRESSION ENHANCES LYMPHOTOXIN PRODUCTION BY B-LYMPHOCYTES

      Methods
    64. HIRAIWA H; HAMAZAKI M; MURATA H; TANIGUCHI K; SAKURAI M
      EPSTEIN-BARR-VIRUS INFECTION, HODGKINS-DISEASE, NON-HODGKINS-LYMPHOMA, AND REACTIVE FOLLICULAR HYPERPLASIA IN JAPANESE CHILDREN - EVALUATION OF PARAFFIN-EMBEDDED SPECIMENS USING POLYMERASE CHAIN-REACTION AND IMMUNOHISTOCHEMISTRY

      Acta Paediatrica Japonica Overseas Edition
    65. MINOGUCHI S; TANIGUCHI Y; KATO H; OKAZAKI T; STROBL LJ; ZIMBERSTROBL U; BORNKAMM GW; HONJO T
      RBP-L, A TRANSCRIPTION FACTOR-RELATED TO RBP-J-KAPPA

      Molecular and cellular biology
    66. KIESER A; KILGER E; GIRES O; UEFFING M; KOLCH W; HAMMERSCHMIDT W
      EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-1 TRIGGERS AP-1 ACTIVITY VIA THE C-JUN N-TERMINAL KINASE CASCADE

      EMBO journal
    67. NITSCHE F; BELL A; RICKINSON A
      EPSTEIN-BARR-VIRUS LEADER PROTEIN ENHANCES EBNA-2-MEDIATED TRANSACTIVATION OF LATENT MEMBRANE-PROTEIN-1 EXPRESSION - A ROLE FOR THE W1W2 REPEAT DOMAIN

      Journal of virology
    68. NEIPEL F; ALBRECHT JC; FLECKENSTEIN B
      CELL-HOMOLOGOUS GENES IN THE KAPOSIS-SARCOMA-ASSOCIATED RHADINOVIRUS HUMAN HERPESVIRUS-8 - DETERMINANTS OF ITS PATHOGENICITY

      Journal of virology
    69. YOO LI; MOONEY M; PUGLIELLI MT; SPECK SH
      B-CELL LINES IMMORTALIZED WITH AN EPSTEIN-BARR-VIRUS MUTANT LACKING THE CP EBNA2 ENHANCER ARE BIASED TOWARD UTILIZATION OF THE ORIP-PROXIMAL EBNA GENE PROMOTER WP1

      Journal of virology
    70. PUGLIELLI MT; DESAI N; SPECK SH
      REGULATION OF EBNA GENE-TRANSCRIPTION IN LYMPHOBLASTOID CELL-LINES - CHARACTERIZATION OF SEQUENCES DOWNSTREAM OF BCR2 (CP)

      Journal of virology
    71. SUGANO N; CHEN WP; ROBERTS ML; COOPER NR
      EPSTEIN-BARR-VIRUS BINDING TO CD21 ACTIVATES THE INITIAL VIRAL PROMOTER VIA NF-KAPPA-B INDUCTION

      The Journal of experimental medicine
    72. NICOLAS JC; MARECHAL V; DEHEE A
      EPSTEIN-BARR-VIRUS

      Bulletin de l'Academie nationale de medecine
    73. CONTRERAS A; SLOTS J
      MAMMALIAN VIRUSES IN HUMAN PERIODONTITIS

      Oral microbiology and immunology
    74. PARRA B; SLOTS J
      DETECTION OF HUMAN VIRUSES IN PERIODONTAL POCKETS USING POLYMERASE CHAIN-REACTION

      Oral microbiology and immunology
    75. ZIMBERSTROBL U; KEMPKES B; MARSCHALL G; ZEIDLER R; VANKOOTEN C; BANCHEREAU J; BORNKAMM GW; HAMMERSCHMIDT W
      EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN (LMP1) IS NOT SUFFICIENT TO MAINTAIN PROLIFERATION OF B-CELLS BUT BOTH IT AND ACTIVATED CD40 CANPROLONG THEIR SURVIVAL

      EMBO journal
    76. SWAMINATHAN S
      CHARACTERIZATION OF EPSTEIN-BARR-VIRUS RECOMBINANTS WITH DELETIONS OFTHE BAMHI-C-PROMOTER

      Virology
    77. PUGLIELLI MT; WOISETSCHLAEGER M; SPECK SH
      ORIP IS ESSENTIAL FOR EBNA GENE PROMOTER ACTIVITY IN EPSTEIN-BARR VIRUS-IMMORTALIZED LYMPHOBLASTOID CELL-LINES

      Journal of virology
    78. WALTZER L; PERRICAUDET M; SERGEANT A; MANET E
      EPSTEIN-BARR-VIRUS EBNA3A AND EBNA3C PROTEINS BOTH REPRESS RBP-J-KAPPA-EBNA2-ACTIVATED TRANSCRIPTION BY INHIBITING THE BINDING OF RBP-J-KAPPA TO DNA

      Journal of virology
    79. YAO QY; TIERNEY RJ; CROOMCARTER D; DUKERS D; COOPER GM; ELLIS CJ; ROWE M; RICKINSON AB
      FREQUENCY OF MULTIPLE EPSTEIN-BARR-VIRUS INFECTIONS IN T-CELL-IMMUNOCOMPROMISED INDIVIDUALS

      Journal of virology
    80. YAO QY; TIERNEY RJ; CROOMCARTER D; COOPER GM; ELLIS CJ; ROWE M; RICKINSON AB
      ISOLATION OF INTERTYPIC RECOMBINANTS OF EPSTEIN-BARR-VIRUS FROM T-CELL-IMMUNOCOMPROMISED INDIVIDUALS

      Journal of virology
    81. YALAMANCHILI R; HARADA S; KIEFF E
      THE N-TERMINAL HALF OF EBNA2, EXCEPT FOR 7 PROLINES, IS NOT ESSENTIALFOR PRIMARY B-LYMPHOCYTE GROWTH TRANSFORMATION

      Journal of virology
    82. KANNO H; YASUNAGA Y; OHSAWA M; TANIWAKI M; IUCHI K; NAKA N; TORIKAI K; SHIMOYAMA M; AOZASA K
      EXPRESSION OF EPSTEIN-BARR-VIRUS LATENT INFECTION GENES AND ONCOGENESIN LYMPHOMA CELL-LINES DERIVED FROM PYOTHORAX-ASSOCIATED LYMPHOMA

      International journal of cancer
    83. CARBONE A; GLOGHINI A; VACCHER E; ZAGONEL V; PASTORE C; DALLAPALMA P; BRANZ F; SAGLIO G; VOLPE R; TIRELLI U; GAIDANO G
      KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS DNA-SEQUENCES IN AIDS-RELATED AND AIDS-UNRELATED LYMPHOMATOUS EFFUSIONS

      British Journal of Haematology
    84. OHSAWA M; TOMITA Y; KANNO H; IUCHI K; KAWABATA Y; NAKAJIMA Y; KOMATSU H; MUKAI K; SHIMOYAMA M; AOZASA K
      ROLE OF EPSTEIN-BARR-VIRUS IN PLEURAL LYMPHOMAGENESIS

      Modern pathology
    85. WALTZER L; BOURILLOT PY; SERGEANT A; MANET E
      RBP-J-KAPPA REPRESSION ACTIVITY IS MEDIATED BY A CO-REPRESSOR AND ANTAGONIZED BY THE EPSTEIN-BARR-VIRUS TRANSCRIPTION FACTOR EBNA2

      Nucleic acids research
    86. ROBERTSON KD; HAYWARD SD; LING PD; SAMID D; AMBINDER RF
      TRANSCRIPTIONAL ACTIVATION OF THE EPSTEIN-BARR-VIRUS LATENCY C PROMOTER AFTER 5-AZACYTIDINE TREATMENT - EVIDENCE THAT DEMETHYLATION AT A SINGLE CPG SITE IS CRUCIAL

      Molecular and cellular biology
    87. KEMPKES B; SPITKOVSKY D; JANSENDURR P; ELLWART JW; KREMMER E; DELECLUSE HJ; ROTTENBERGER C; BORNKAMM GW; HAMMERSCHMIDT W
      B-CELL PROLIFERATION AND INDUCTION OF EARLY G(1)-REGULATING PROTEINS BY EPSTEIN-BARR-VIRUS MUTANTS CONDITIONAL FOR EBNA2

      EMBO journal
    88. HSIEH JJD; HAYWARD SD
      MASKING OF THE CBF1 RBPJ(KAPPA) TRANSCRIPTIONAL REPRESSION DOMAIN BY EPSTEIN-BARR-VIRUS EBNA2/

      Science
    89. GAHN TA; SUGDEN B
      AN EBNA-1-DEPENDENT ENHANCER ACTS FROM A DISTANCE OF 10-KILOBASE PAIRS TO INCREASE EXPRESSION OF THE EPSTEIN-BARR-VIRUS LMP GENE

      Journal of virology
    90. LING PD; HAYWARD SD
      CONTRIBUTION OF CONSERVED AMINO-ACIDS IN MEDIATING THE INTERACTION BETWEEN EBNA2 AND CBF1 RBPJK/

      Journal of virology
    91. SINCLAIR AJ; PALMERO I; HOLDER A; PETERS G; FARRELL PJ
      EXPRESSION OF CYCLIN D2 IN EPSTEIN-BARR VIRUS-POSITIVE BURKITTS-LYMPHOMA CELL FINES IS RELATED TO METHYLATION STATUS OF THE GENE

      Journal of virology
    92. DELECLUSE HJ; KREMMER E; ROUAULT JP; COUR C; BORNKAMM G; BERGER F
      THE EXPRESSION OF EPSTEIN-BARR-VIRUS LATENT PROTEINS IS RELATED TO THE PATHOLOGICAL FEATURES OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS

      The American journal of pathology
    93. HENDERSON SA; HUEN D; ROWE M
      EPSTEIN-BARR-VIRUS TRANSFORMING PROTEIN

      Seminars in virology
    94. FAHRAEUS R; PALMQVIST L; NERDSTEDT A; FARZAD S; RYMO L; LAIN S
      RESPONSE TO CAMP LEVELS OF THE EPSTEIN-BARR-VIRUS EBNA2-INDUCIBLE LMP1 ONCOGENE AND EBNA2 INHIBITION OF A PP1-LIKE ACTIVITY

      EMBO journal
    95. WALTZER L; LOGEAT F; BROU C; ISRAEL A; SERGEANT A; MANET E
      THE HUMAN J-KAPPA RECOMBINATION SIGNAL SEQUENCE BINDING-PROTEIN (RBP-J-KAPPA) TARGETS THE EPSTEIN-BARR-VIRUS EBNA2 PROTEIN TO ITS DNA RESPONSIVE ELEMENTS

      EMBO journal
    96. SINCLAIR AJ; PALMERO I; PETERS G; FARRELL PJ
      EBNA-2 AND EBNA-LP COOPERATE TO CAUSE G(0) TO G(1) TRANSITION DURING IMMORTALIZATION OF RESTING HUMAN B-LYMPHOCYTES BY EPSTEIN-BARR-VIRUS

      EMBO journal
    97. YALAMANCHILI R; TONG X; GROSSMAN S; JOHANNSEN E; MOSIALOS G; KIEFF E
      GENETIC AND BIOCHEMICAL-EVIDENCE THAT EBNA-2 INTERACTION WITH A 63-KDA CELLULAR GTG-BINDING PROTEIN IS ESSENTIAL FOR B-LYMPHOCYTE GROWTH TRANSFORMATION BY EBV

      Virology
    98. MINAROVITS J; HU LF; MINAROVITSKORMUTA S; KLEIN G; ERNBERG I
      SEQUENCE-SPECIFIC METHYLATION INHIBITS THE ACTIVITY OF THE EPSTEIN-BARR-VIRUS-LMP 1 AND BCR2 ENHANCER-PROMOTER REGIONS

      Virology
    99. HENKEL T; LING PD; HAYWARD SD; PETERSON MG
      MEDIATION OF EPSTEIN-BARR-VIRUS EBNA2 TRANSACTIVATION BY RECOMBINATION SIGNAL-BINDING PROTEIN J(K)

      Science
    100. LING PD; HSIEH JJD; RUF IK; RAWLINS DR; HAYWARD SD
      EBNA-2 UP-REGULATION OF EPSTEIN-BARR-VIRUS LATENCY PROMOTERS AND THE CELLULAR CD23 PROMOTER UTILIZES A COMMON TARGETING INTERMEDIATE, CBF1

      Journal of virology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/10/20 alle ore 23:26:59